title: Changes in vasoactive properties of blood products with time and attempted identification of the spasmogens.
abstract: The contractile activity of various fresh, or incubated blood fractions was studied in vitro using the isolated canine basilar artery. Significantly greater contraction was induced by fresh platelet rich plasma (PRP) and serum compared to red blood cells (RBC). Following incubation, the contractile activity of RBC increased, reaching a plateau at day-3 and it was maintained for at least 14 days, while both PRP and serum lost most of their activity after 24 h of incubation. The contractions induced by fresh blood fractions were only partially blocked by desensitization of 5-hydroxytryptamine (5-HT) receptors or by the 5-HT antagonist methysergide. D-600 effectively antagonized the response to all blood fractions. Biochemical analysis of the incubated RBC by means of Sephacryl S-200 column chromatography and SDS-urea polyacrylamide gel electrophoresis revealed that the contractile substance possessed a molecular weight of about 60,000 daltons. Vasoactivity was only present in one peak of the chromatographically eluted fractions which was shown to possess a similar absorption spectrum to that of hemoglobin. Hemoglobin concentration was highest in day 3, 7, and 14 fractions and may be correlated with the contractile activity of incubated samples.
mesh_terms: D000818:Animals; D001790:Blood Physiological Phenomena; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000032:analysis; D005260:Female; D005711:Gallopamil / Q000494:pharmacology; D006454:Hemoglobins / Q000502:physiology; D066298:In Vitro Techniques; D002546:Ischemic Attack, Transient / Q000097:blood; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000097:blood
chemical_list: D006454:Hemoglobins; D014662:Vasoconstrictor Agents; D012701:Serotonin; D005711:Gallopamil; D008784:Methysergide